|
21KR
A Wnt3a/Fzd8-CRD/LRP6-E3E4 complex with FKBP
Deposited 2025-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain C
31–155(125 aa)
Chain D
31–155(125 aa)
Chain G
31–155(125 aa)
Chain H
31–155(125 aa)
Chain I
31–155(125 aa)
|
Mutation:C178S
Mutation:C178S
Mutation:C178S
Mutation:C178S
Mutation:C178S
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 2.90 Å
|
|
21KS
A Wnt3a/Fzd8-CRD/LRP6-E3E4-LA complex with FKBP
Deposited 2025-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain C
31–155(125 aa)
Chain D
31–155(125 aa)
Chain G
31–155(125 aa)
Chain H
31–155(125 aa)
Chain I
31–155(125 aa)
|
Mutation:C178S
Mutation:C178S
Mutation:C178S
Mutation:C178S
Mutation:C178S
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 3.01 Å
|
|
21KT
Wnt3a signalosome extracellular complex
Deposited 2025-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain C
31–155(125 aa)
Chain D
31–155(125 aa)
Chain G
31–155(125 aa)
Chain H
31–155(125 aa)
|
Mutation:Q159A,E161A,C178S,Q221A
Mutation:Q159A,E161A,C178S,Q221A
Mutation:Q159A,E161A,C178S,Q221A
Mutation:Q159A,E161A,C178S,Q221A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 3.33 Å
|
|
5UN5
Frizzled-8 complex with designed surrogate Wnt agonist, crystal form 1
Deposited 2017-01-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
28–150(123 aa)
Fragment:UNP residues 28-150
Chain B
28–150(123 aa)
Fragment:UNP residues 28-150
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;42-49% PEG 400, 0.1 M Tris pH 7.8-8.2, 0.2 M NaCl
|
Resolution 2.99 Å
R-free 0.250
|
|
5UN6
Frizzled-8 complex with designed surrogate Wnt agonist, A1 dataset
Deposited 2017-01-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
28–150(123 aa)
Fragment:UNP residues 28-150
|
Mutation:Q22N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;20% PEG 3000, 0.1 M Sodium citrate pH 5.5
|
Resolution 3.20 Å
R-free 0.247
|
|
5UN6
Frizzled-8 complex with designed surrogate Wnt agonist, A1 dataset
Deposited 2017-01-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
28–150(123 aa)
Fragment:UNP residues 28-150
|
Mutation:Q22N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;20% PEG 3000, 0.1 M Sodium citrate pH 5.5
|
Resolution 3.20 Å
R-free 0.247
|
|
5UN6
Frizzled-8 complex with designed surrogate Wnt agonist, A1 dataset
Deposited 2017-01-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
28–150(123 aa)
Fragment:UNP residues 28-150
|
Mutation:Q22N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;20% PEG 3000, 0.1 M Sodium citrate pH 5.5
|
Resolution 3.20 Å
R-free 0.247
|
|
5UN6
Frizzled-8 complex with designed surrogate Wnt agonist, A1 dataset
Deposited 2017-01-30
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
28–150(123 aa)
Fragment:UNP residues 28-150
|
Mutation:Q22N
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;20% PEG 3000, 0.1 M Sodium citrate pH 5.5
|
Resolution 3.20 Å
R-free 0.247
|
|
8X0T
Frizzled8 CRD in complex with pF8_AC3 Fab
Deposited 2023-11-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
30–153(124 aa)
|
Mutation:N49Q
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;295 K;32% PEG4000, 0.1 M Tris, pH 8.5, 0.2 M MgCl2
|
Resolution 2.50 Å
R-free 0.290
|